FLI
TMO icon

Family Legacy Inc’s Thermo Fisher Scientific TMO Stock Holding History

Family Legacy Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Sell
2,766
-8
-0.3% -$3.84K 0.37% 75
2026
Q1 		$1.36M Buy
2,774
+27
+1% +$14.7K 0.41% 75
2025
Q4 		$1.59M Buy
2,747
+16
+0.6% +$9.05K 0.48% 70
2025
Q3 		$1.32M Buy
2,731
+4
+0.1% +$1.86K 0.41% 74
2025
Q2 		$1.11M Buy
2,727
+37
+1% +$15.5K 0.36% 82
2025
Q1 		$1.34M Buy
2,690
+26
+1% +$14.1K 0.46% 72
2024
Q4 		$1.45M Buy
2,664
+147
+6% +$80.8K 0.49% 69
2024
Q3 		$1.56M Buy
2,517
+107
+4% +$63.3K 0.52% 68
2024
Q2 		$1.33M Buy
2,410
+42
+2% +$24.1K 0.48% 68
2024
Q1 		$1.38M Buy
2,368
+67
+3% +$37.6K 0.49% 71
2023
Q4 		$1.22M Buy
2,301
+106
+5% +$51.3K 0.47% 72
2023
Q3 		$1.11M Buy
2,195
+67
+3% +$35.7K 0.46% 70
2023
Q2 		$1.11M Buy
2,128
+26
+1% +$14K 0.45% 73
2023
Q1 		$1.21M Buy
2,102
+170
+9% +$95.8K 0.52% 70
2022
Q4 		$1.11M Buy
+1,932
New +$1.02M 0.49% 70

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Family Legacy Inc's TMO Position: Q2 2026 in Review

Family Legacy Inc reduced its Thermo Fisher Scientific (TMO) stake by 0.29% in Q2 2026, selling an estimated $3.84K and leaving 2,766 shares worth $1.39M. The position accounts for 0.37% of the portfolio, ranked #75.

Family Legacy Inc first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.59M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Family Legacy Inc held 2,766 shares of Thermo Fisher Scientific worth $1.39M as of Q2 2026.
  • Family Legacy Inc sold 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
  • Thermo Fisher Scientific made up 0.37% of Family Legacy Inc's portfolio in Q2 2026, its #75 holding.
  • Family Legacy Inc first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Family Legacy Inc's Thermo Fisher Scientific position peaked at $1.59M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Family Legacy Inc's 13F filing for Q2 2026, filed 6 Aug 2026.